Skip to content

Price / sales at other companies

Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
210.5×-3,896×
uniQure logo
uniQureQURE
169.6×+115×
AdaptHealth logo
AdaptHealthAHCO
0.5×0.0×
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
8.8×-6.6×
CalAmp logo
CalAmpCAMP
58.2×+4.8×

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$43.8M-15.8%
Net income-$41.3M-15.0%
EPS (diluted)-$0.37+11.9%

Balance sheet

See full
Cash & equivalents$229.1M+283%
Total debt$5.6M+307%
Total equity$273.2M+35.6%
Total assets$293.6M+33.7%

Cash flow

See full
Operating cash flow-$36.9M+7.4%
CapEx$86.0K+330%
Free cash flow-$28.0M+52.6%

Valuation

See full
Market cap$2.17B+204%
Enterprise value$1.94B+194%

Profitability

See full
Gross margin100%+6.9pp
Operating margin-47,349.8%-47,409pp
Net margin-45,096.2%-45,152pp
FCF margin-39,826.7%-39,847pp

Returns & leverage

See full
Return on equity-63.3%-12.2pp
Debt / equity0.0×
Current ratio17.9×+5.8×

Where this comes from

Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Amylyx Pharmaceuticals, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amylyx Pharmaceuticals, Inc.'s price / sales?
Amylyx Pharmaceuticals, Inc. (AMLX) reported price / sales of 1,373.5× in Q2 2025.
How has Amylyx Pharmaceuticals, Inc.'s price / sales changed year-over-year?
Amylyx Pharmaceuticals, Inc.'s price / sales increased by 318218.5% year-over-year, from 0.4× to 1,373.5×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.